key: cord-0940034-a9uybz60
authors: Wei, Meili; Zhao, Yongjie; Qian, Zhuoyu; Yang, Biao; Xi, Jun; Wei, Jun; Tang, Bikui
title: Pneumonia caused by Mycobacterium tuberculosis
date: 2020-06-16
journal: Microbes Infect
DOI: 10.1016/j.micinf.2020.05.020
sha: aaac7c3426deffa229fb4538f789970bf3bcd72e
doc_id: 940034
cord_uid: a9uybz60

Tuberculosis (TB) is one of the top ten leading causes of death worldwide. The causative agent of TB is Mycobacterium tuberculosis. Acute tuberculous pneumonia (TP) is an acute form of pulmonary TB. However, acute TP and non-tuberculous community-acquired pneumonia can be easily confused, resulting in deterioration of TP due to delayed treatment. Therefore, rapid and accurate diagnosis of acute TP is crucial in order to stop the transmission of TB. Moreover, development of new diagnostic tools (technologies and approaches), and flexible application of different therapy schemes will help to reduce the incidence of TP and promote the goal of ending the TB epidemic.

[18]. Otherwise, the disease will progress, and more necrotic cavities will spread to other are-88 as of the lungs. Permanent lesions may occur, such as bronchostenosis. If the lesion is located 89 in middle lobe or lingula, it will cause advanced complications such as bleeding and recurrent 90 bacterial pneumonia [19] . 91 1.3 TB and pneumonia 92 The incidence of pneumonia in PTB patients is higher than that in normal groups [20] . In 93 some areas, such as Uganda, epidemiological analysis has shown that children with severe 94 pneumonia have a higher incidence of PTB, accounting for 18.9% [21] . A recent study has 95 shown that in CAP patients with streptococcus pneumoniae and M. tuberculosis coinfection, 96 pneumococcal pneumonia is likely to provide fertile ground for reactivation of latent TB [22] . 97 In patients with multidrug-resistant TB (MDR-TB), long-term use of medication increases the 98 risk of secondary pneumonia. In turn, secondary pneumonia significantly delays in smear 99 conversion to negative in patients with MDR-TB. This is also a cause to TB treatment failure Imaging test: Medical imaging is an indispensable test in the diagnosis of acute TP. 115 Morphological feature analysis of lesion is a pivotal basis for imaging diagnosis for acute TP. 116 The radiographic characteristic of TP is homogeneous, segmental consolidation on CXR, 117 which is interpreted by chest radiologists as bacterial pneumonia [25] . A retrospective study 118 on 59 TP patients found that pulmonary consolidation of most cases (67.8%) appeared in up-119 per lobes, with the right lobe predominate. 9 cases' pulmonary consolidation were found in 120 the middle lobe [7].

If a chest computed tomography (CT) scan is performed, the result will also be homoge- 

The TS-SPOT assay, which is also based on IFN-γ detection, has the characteristics of low 

Pulmonary tuberculosis with 523 acute respiratory failure

Immune regulation by glucocorticoids

Corticosteroids for prevention of mortality in 527 people with tuberculosis: a systematic review and meta-analysis

Tuberculosis meningitis

Mycobacterium tuberculosis-532 associated necrotizing pneumonia with adjunctive corticosteroid therapy

Resolvin D1 (RvD1) and maresin 1 (Mar1) 535 contribute to human macrophage control of M. tuberculosis infection while resolving 536 inflammation

Chronic lung 538 disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study

Successfully treated but 541 not fit for purpose: paying attention to chronic lung impairment after TB treatment

Effect of diagnostic and 544 treatment delay on the risk of tuberculosis transmission in Shenzhen, China: an 545 observational cohort study

Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study

Imaging of pulmonary post-tuberculosis sequelae

The immune 552 mechanisms of lung parenchymal damage in tuberculosis and the role of host-directed 553 therapy

Sinomenine protects against E. coli-555 induced acute lung injury in mice through Nrf2-NF-κB pathway

The antioxidant effects 558 of Radix Astragali (Astragalus membranaceus and related species) in protecting tissues 559 from injury and disease

Environment, global climate change, and cardiopulmonary health

Vaccination against tuberculosis

Childhood tuberculosis: old and new vaccines

Prevention of tuberculosis in macaques after intravenous BCG immunization

Selective 580 delipidation of Mycobacterium bovis BCG enables direct pulmonary vaccination and 581 enhances protection against Mycobacterium tuberculosis

Safety 584 and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated 585 with BCG: a randomised, placebo-controlled phase 2b trial

Saccharomyces cerevisiae-based therapeutic vaccine against tuberculosis

The current status, challenges, and future developments of new 590 tuberculosis vaccines